Current Oncology, 2022
Featured Publications
Gynecologic Oncology, 2022
PubMed: 35246332
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
Current Oncology, 2022
PubMed: 35448189
The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis
Journal of Clinical Pathology, 2021
PubMed: 32467321
Reduced sensitivity for EGFR T790M mutations using the Idylla EGFR Mutation Test
N/A, 2021
Is endometriosis metastasizing? Shared somatic alterations suggest common origins across endometriotic lesions
Modern Pathology, 2021
PubMed: 32792599
Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome
American Association for Cancer Research, 2020
Abstract A07: Sequential ctDNA analysis detected preclinical relapse in patients with metastatic colorectal cancer from the Exactis trial (NCT00984048)
Pathology, 2020
PubMed: 32359774
Prevalence of the EGFR T790M and other resistance mutations in the Australian population and histopathological correlation in a small subset of cases
International Journal of Gynecologic Cancer, 2019
49 Circulating cell-free tumour dna for surveillance of endometrial and ovarian carcinoma
Recent Resources
Blog
June 5, 2023
Revolutionizing Endometrial Cancer Classification: The Impact of the Endometrial Promise Classifier
To discuss the development of the Endometrial ProMisE Molecular Classifier, and the new NSMP study further, we are delighted to have Dr. Jessica McAlpine and Dr. Amy Jamieson, esteemed gynecological cancer surgeons at Vancouver General Hospital, who have been instrumental in the development and implementation of this innovative tool.
Blog
May 15, 2023
Poster sessions at AACR: a recap
We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.
Press
March 28, 2023
Imagia Canexia Health Announces Three Abstracts to be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Latest Research Findings
Imagia Canexia Health announced that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.
Webinar
March 27, 2023
Project ACTT Webinar
Project ACTT (Access to Cancer Testing and Treatment) in Response to COVID-19 was a joint effort led by Imagia Canexia Health and supported by Digital Supercluster and partner institutions.
Blog
February 3, 2023
Cutting-edge precision oncology, where the patient is
The theme for this year’s World Cancer Day is Close the Care Gap. Health equity is a pillar of our work at Imagia Canexia Health. So today our Chief Medical Officer, Dr. David Huntsman, is opening the conversation to showcase how our community-centered approach to cancer care is improving access to genomic-driven cancer care for all.
Blog
December 7, 2022
A look back at the history of the Human Genome Project
Read about the history of the Human Genome Project.